Skip to content
Back to RAPP

Rapport Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
83
Purchases
11
Sales
72
Purchase value
$22.02M
Sale value
$47.22M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

James HealyDirector
4
Filed Oct 30, 2026Period of report Oct 28, 20260001104659-26-120789
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 28, 2026
Common StockF1952,380$21.00$20.00M2,815,707IndirectBy Sofinnova Venture Partners XI, L.P.
PurchaseOct 28, 2026
Common StockF26,395$21.00$134.30K17,990IndirectBy SummitTX Master, SPC -SummitTX Apex SP - Healthcare 3
PurchaseOct 28, 2026
Common StockF33,772$21.00$79.21K14,924IndirectBy SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3
PurchaseOct 28, 2026
Common StockF46,933$21.00$145.59K25,267IndirectBy SummitTX Pinnacle Master, L.P. - Healthcare 3
Filing footnotes · 4
  1. F1The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  2. F2The shares are directly held by SummitTX Master, SPC - SummitTX Apex SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - Crestline Summit Apex SP) ("Apex SP"). Sofinnova BioEquities GP LLC ("BioEquities GP") is the general partner of Apex SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Apex SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  3. F3The shares are directly held by SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - PEAK SP) ("Alpha SP"). BioEquities GP is the general partner of Alpha SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Alpha SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  4. F4The shares are directly held by SummitTX Pinnacle Master, L.P. - Healthcare 3 (f/k/a Crestline Summit Pinnacle Master, L.P.) ("Pinnacle LP"). BioEquities GP is the general partner of Pinnacle LP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Pinnacle LP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
Ramiro SanchezDirector
4
Filed Oct 23, 2026Period of report Oct 23, 20260001193125-26-430397
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 23, 2026
Common StockF13,600$27.3549$98.48K3,600Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.07 to $27.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Open on SEC EDGAR
Paul M SilvaDirector
4
Filed Oct 22, 2026Period of report Oct 22, 20260001193125-26-429075
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 22, 2026
Common Stock3,680$27.075$99.64K3,680IndirectBy Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016
Open on SEC EDGAR
Wendy B. YoungDirector
4
Filed Oct 22, 2026Period of report Oct 22, 20260001193125-26-429074
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 22, 2026
Common Stock3,789$26.39$99.99K13,289Direct
Open on SEC EDGAR
Steven M PaulDirector
4
Filed Oct 22, 2026Period of report Oct 22, 20260001193125-26-429073
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 22, 2026
Common StockF1F235,714$27.28$974.28K77,380IndirectBy Paul Capital Strategy III Fund LLC
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.87 to $27.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
  2. F2Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
Open on SEC EDGAR
John MaraganoreDirector
4
Filed Oct 22, 2026Period of report Oct 22, 20260001193125-26-429071
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 22, 2026
Common StockF18,239$26.3799$217.34K8,239IndirectBy John M. Maraganore Revocable Trust
PurchaseOct 22, 2026
Common StockF21,172$26.9173$31.55K9,411IndirectBy John M. Maraganore Revocable Trust
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.81 to $26.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
  2. F2The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.81 to $26.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Oct 23, 2026Period of report Oct 21, 20260001193125-26-430504
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 21, 2026
Common StockF1F22,210$29.1618$64.45K450,035Direct
Filing footnotes · 2
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.89 to $29.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Troy A. IgnelziChief Financial Officer
4
Filed Oct 21, 2026Period of report Oct 21, 20260001193125-26-428018
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 21, 2026
Common Stock5,500$26.10$143.55K15,500Direct
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Oct 8, 2026Period of report Oct 6, 20260001193125-26-417919
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 7, 2026
Common StockF1F31,147$30.66$35.17K452,245Direct
SaleOct 6, 2026
Common StockF1F23,375$32.0314$108.11K453,392Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.65 to $32.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.33 to $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Cheryl GaultChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Oct 1, 2026Period of report Sep 30, 20260001193125-26-410734
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 30, 2026
Common StockF1F27,925$33.0364$261.81K141,989Direct
SaleSep 30, 2026
Common StockF1F32,075$33.7556$70.04K139,914Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.64 to $33.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.64 to $34.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Sep 24, 2026Period of report Sep 23, 20260001193125-26-401017
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 23, 2026
Common StockF1F21,952$39.0523$76.23K457,025Direct
SaleSep 23, 2026
Common StockF1F3215$39.8602$8.57K456,810Direct
SaleSep 23, 2026
Common StockF143$41.05$1.77K456,767Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.54 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.57 to $40.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Sep 9, 2026Period of report Sep 8, 20260001193125-26-386436
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 8, 2026
Common StockF1F27,141$45.555$325.31K460,046Direct
SaleSep 8, 2026
Common StockF1F31,069$46.0147$49.19K458,977Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.94 to $45.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.95 to $46.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Aug 26, 2026Period of report Aug 25, 20260001193125-26-368285
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 25, 2026
Common StockF1F218,921$49.5723$937.96K467,187Direct
Filing footnotes · 2
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.03 to $50.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4Rule 10b5-1 plan disclosed
Filed Aug 26, 2026Period of report Aug 24, 20260001193125-26-368244
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 25, 2026
Common StockF1F320,799$50.3111$1.05M212,063Direct
SaleAug 25, 2026
Common StockF1F416,201$51.0576$827.18K195,862Direct
SaleAug 24, 2026
Common StockF1F213,160$49.9983$657.98K232,862Direct
Filing footnotes · 4
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.90 to $50.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.90 to $50.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.91 to $51.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4Rule 10b5-1 plan disclosed
Filed Aug 20, 2026Period of report Aug 19, 20260001193125-26-359189
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 19, 2026
Common StockF1404$49.90$20.16K246,022Direct
Filing footnotes · 1
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Aug 12, 2026Period of report Aug 10, 20260001193125-26-346995
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 11, 2026
Common StockF1F43,664$46.8988$171.84K511,402Direct
SaleAug 11, 2026
Common StockF1F519,500$48.0434$936.85K491,902Direct
SaleAug 11, 2026
Common StockF1F65,794$48.6229$281.72K486,108Direct
SaleAug 10, 2026
Common StockF1F214,171$45.9736$651.49K523,436Direct
SaleAug 10, 2026
Common StockF1F38,370$46.7479$391.28K515,066Direct
Filing footnotes · 6
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.37 to $46.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.38 to $47.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.32 to $47.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.45 to $48.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.45 to $48.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jul 29, 2026Period of report Jul 27, 20260001193125-26-323637
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 27, 2026
Common StockF1F22,203$42.107$92.76K537,614Direct
SaleJul 27, 2026
Common StockF17$42.735$299.15537,607Direct
Filing footnotes · 4
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.66 to $42.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  4. F4Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jul 15, 2026Period of report Jul 14, 20260001193125-26-304786
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 14, 2026
Common StockF1F25,481$39.7217$217.71K542,546Direct
SaleJul 14, 2026
Common StockF1F32,729$40.5724$110.72K539,817Direct
Filing footnotes · 5
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.36 to $40.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.37 to $40.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  5. F5Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
Cheryl GaultChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Jul 1, 2026Period of report Jun 30, 20260001193125-26-292546
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 30, 2026
Common StockF1F21,900$40.0914$76.17K158,014Direct
SaleJun 30, 2026
Common StockF1F33,792$41.3934$156.96K154,222Direct
SaleJun 30, 2026
Common StockF1F43,308$42.1722$139.51K150,914Direct
SaleJun 30, 2026
Common StockF1F51,000$43.1547$43.15K149,914Direct
Filing footnotes · 5
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.61 to $40.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.80 to $41.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.81 to $43.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jul 1, 2026Period of report Jun 29, 20260001193125-26-292519
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 29, 2026
Common StockF1F27,344$39.7688$292.06K548,903Direct
SaleJun 29, 2026
Common StockF1F3876$40.3375$35.34K548,027Direct
Filing footnotes · 5
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.25 to $40.225, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  5. F5Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
Third Rock Ventures GP VI, L.P.10% owner
Third Rock Ventures GP V, LP10% owner
Third Rock Ventures VI, L.P.10% owner
Third Rock Ventures V, L.P.10% owner
TRV GP VI, LLC10% owner
TRV GP V, LLC10% owner
4Rule 10b5-1 plan disclosed
Filed May 28, 2026Period of report May 26, 20260001193125-26-245259
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 26, 2026
Common StockF1F2F318,572$40.047$743.75K6,280,525Direct
Filing footnotes · 4
  1. F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 21, 2025, previously adopted by the Reporting Person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  3. F3These shares are directly held by Third Rock Ventures V, L.P. ("TRV V"). The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
  4. F4The shares are held directly by Third Rock Ventures VI, L.P. ("TRV VI"). The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI, and TRV GP VI LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
Open on SEC EDGAR
Third Rock Ventures GP VI, L.P.10% owner
Third Rock Ventures GP V, LP10% owner
Third Rock Ventures VI, L.P.10% owner
Third Rock Ventures V, L.P.10% owner
TRV GP VI, LLC10% owner
TRV GP V, LLC10% owner
4Rule 10b5-1 plan disclosed
Filed May 13, 2026Period of report May 11, 20260001193125-26-222185
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Common StockF1F2F3133,618$40.244$5.38M6,299,097Direct
Filing footnotes · 4
  1. F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 21, 2025, previously adopted by the Reporting Person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  3. F3These shares are directly held by Third Rock Ventures V, L.P. ("TRV V"). The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
  4. F4The shares are held directly by Third Rock Ventures VI, L.P. ("TRV VI"). The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI, and TRV GP VI LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
Open on SEC EDGAR
Third Rock Ventures GP VI, L.P.10% owner
Third Rock Ventures GP V, LP10% owner
Third Rock Ventures VI, L.P.10% owner
Third Rock Ventures V, L.P.10% owner
TRV GP VI, LLC10% owner
TRV GP V, LLC10% owner
4Rule 10b5-1 plan disclosed
Filed May 11, 2026Period of report May 7, 20260001193125-26-217092
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 8, 2026
Common StockF1F4F35,018$40.306$202.26K6,432,715Direct
SaleMay 7, 2026
Common StockF1F2F3271,495$40.121$10.89M6,437,733Direct
Filing footnotes · 5
  1. F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 21, 2025, previously adopted by the Reporting Person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  3. F3These shares are directly held by Third Rock Ventures V, L.P. ("TRV V"). The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
  4. F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.10 to $40.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4).
  5. F5The shares are held directly by Third Rock Ventures VI, L.P. ("TRV VI"). The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI, and TRV GP VI LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
Open on SEC EDGAR
Third Rock Ventures GP VI, L.P.10% owner
Third Rock Ventures GP V, LP10% owner
Third Rock Ventures VI, L.P.10% owner
Third Rock Ventures V, L.P.10% owner
TRV GP VI, LLC10% owner
TRV GP V, LLC10% owner
4Rule 10b5-1 plan disclosed
Filed Apr 21, 2026Period of report Apr 17, 20260001193125-26-167636
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 17, 2026
Common StockF1F2F3426,005$40.317$17.18M6,709,228Direct
Filing footnotes · 4
  1. F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 21, 2025, previously adopted by the Reporting Person.
  2. F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  3. F3These shares are directly held by Third Rock Ventures V, L.P. ("TRV V"). The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
  4. F4The shares are held directly by Third Rock Ventures VI, L.P. ("TRV VI"). The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI, and TRV GP VI LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4Rule 10b5-1 plan disclosed
Filed Apr 21, 2026Period of report Apr 17, 20260001193125-26-167091
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 17, 2026
Common StockF1F220,225$39.9923$808.84K246,426Direct
Filing footnotes · 2
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4Rule 10b5-1 plan disclosed
Filed Apr 14, 2026Period of report Apr 10, 20260001193125-26-154908
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 14, 2026
Common StockF1F310,200$35.0781$357.80K266,651Direct
SaleApr 13, 2026
Common StockF1F29,165$34.974$320.54K276,851Direct
SaleApr 10, 2026
Common StockF1500$34.98$17.49K286,016Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.90 to $35.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.90 to $35.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4Rule 10b5-1 plan disclosed
Filed Apr 9, 2026Period of report Apr 8, 20260001193125-26-149725
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 8, 2026
Common StockF1360$34.90$12.56K286,516Direct
Filing footnotes · 1
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
Open on SEC EDGAR
Cheryl GaultChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Mar 31, 2026Period of report Mar 30, 20260001193125-26-134684
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 30, 2026
Common StockF1F27,161$28.0401$200.80K162,753Direct
SaleMar 30, 2026
Common StockF1F32,839$28.553$81.06K159,914Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.42 to $28.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.42 to $28.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4Rule 10b5-1 plan disclosed
Filed Mar 26, 2026Period of report Mar 25, 20260001193125-26-126410
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 25, 2026
Common StockF1F210,115$29.9906$303.35K286,876Direct
Filing footnotes · 2
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.90 to $30.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Cheryl GaultChief Operating Officer
4
Filed Mar 9, 2026Period of report Mar 5, 20260001193125-26-098488
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 5, 2026
Common StockF1F22,014$28.93$58.27K169,914Direct
Filing footnotes · 2
  1. F1Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.34 to $28.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 19, 2026Period of report Feb 18, 20260001193125-26-059886
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF1F23,552$29.0516$103.19K558,528Direct
SaleFeb 18, 2026
Common StockF1F32,281$29.7983$67.97K556,247Direct
SaleFeb 18, 2026
Common StockF1F4F62,983$29.0443$86.64K22,829IndirectBy Dorothy Ceesay Irrevocable Trust
SaleFeb 18, 2026
Common StockF1F5F62,100$29.7965$62.57K20,729IndirectBy Dorothy Ceesay Irrevocable Trust
Filing footnotes · 7
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.51 to $29.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.56 to $30.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.51 to $29.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.52 to $30.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  6. F6Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  7. F7Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
David BredtChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Feb 19, 2026Period of report Feb 17, 20260001193125-26-059883
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF1F2900$28.0211$25.22K394,675Direct
SaleFeb 17, 2026
Common StockF1F35,400$28.9497$156.33K389,275Direct
SaleFeb 17, 2026
Common StockF1F42,200$29.5944$65.11K387,075Direct
Filing footnotes · 6
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.39 to $28.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.40 to $29.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.45 to $29.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5Transaction involved a cash exercise of options to purchase shares of the Issuer's common stock. No shares of the Issuer's common stock were sold as part of this transaction.
  6. F625% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jan 22, 2026Period of report Jan 20, 20260001193125-26-019820
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 20, 2026
Common StockF1F25,833$26.1158$152.33K562,080Direct
SaleJan 20, 2026
Common StockF1F3F45,083$26.114$132.74K25,812IndirectBy Dorothy Ceesay Irrevocable Trust
Filing footnotes · 5
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.83 to $26.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.83 to $26.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  5. F5Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
David BredtChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Jan 16, 2026Period of report Jan 15, 20260001193125-26-015350
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 15, 2026
Common StockF1F28,300$26.8255$222.65K395,775Direct
SaleJan 15, 2026
Common StockF1200$27.40$5.48K395,575Direct
Filing footnotes · 2
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.33 to $27.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
David BredtChief Scientific Officer
4
Filed Jan 5, 2026Period of report Dec 31, 20250001193125-26-002470
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 31, 2025
Common StockF2F36,567$30.0499$197.34K404,075Direct
Filing footnotes · 3
  1. F1On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025.
  2. F2Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.04 to $30.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Open on SEC EDGAR
Krishnaswamy YeleswaramChief Development Officer
4
Filed Jan 5, 2026Period of report Dec 31, 20250001193125-26-002469
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 31, 2025
Common StockF22,840$30.05$85.34K296,991Direct
Filing footnotes · 2
  1. F1On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025.
  2. F2Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 17, 20250001193125-25-324826
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F22,441$28.8378$70.39K571,305Direct
SaleDec 17, 2025
Common StockF1F32,792$30.0365$83.86K568,513Direct
SaleDec 17, 2025
Common StockF1F4600$31.036$18.62K567,913Direct
SaleDec 17, 2025
Common StockF1F5F82,147$28.8425$61.92K33,831IndirectBy Dorothy Ceesay Irrevocable Trust
SaleDec 17, 2025
Common StockF1F6F82,421$30.0378$72.72K31,410IndirectBy Dorothy Ceesay Irrevocable Trust
SaleDec 17, 2025
Common StockF1F7F8515$31.0396$15.99K30,895IndirectBy Dorothy Ceesay Irrevocable Trust
Filing footnotes · 9
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.62 to $29.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.72 to $30.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.78 to $31.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.62 to $29.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.72 to $30.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  7. F7The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.75 to $31.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  8. F8Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  9. F9Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
David BredtChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 15, 20250001193125-25-321142
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 15, 2025
Common StockF1F27,704$29.9469$230.71K393,438Direct
SaleDec 15, 2025
Common StockF1F3796$30.6772$24.42K392,642Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.58 to $30.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.61 to $30.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR
Cheryl GaultChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Dec 1, 2025Period of report Nov 26, 20250001193125-25-303910
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 26, 2025
Common StockF1F25,000$30.0973$150.49K171,928Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F325% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Open on SEC EDGAR
Abraham CeesayDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Nov 18, 2025Period of report Nov 17, 20250001193125-25-286218
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 17, 2025
Common StockF1F22,777$24.9246$69.22K576,802Direct
SaleNov 17, 2025
Common StockF1F33,056$25.4303$77.71K573,746Direct
SaleNov 17, 2025
Common StockF1F4F52,242$24.9107$55.85K38,819IndirectBy Dorothy Ceesay Irrevocable Trust
SaleNov 17, 2025
Common StockF1F6F52,841$25.437$72.27K35,978IndirectBy Dorothy Ceesay Irrevocable Trust
Filing footnotes · 7
  1. F1These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.22 to $25.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.22 to $25.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.21 to $25.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.23 to $25.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  7. F7Shares held by The Ceesay Family Irrevocable Trust u/t/d March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open on SEC EDGAR
David BredtChief Scientific Officer
4Rule 10b5-1 plan disclosed
Filed Nov 18, 2025Period of report Nov 17, 20250001193125-25-286212
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 17, 2025
Common StockF1F23,156$24.8399$78.39K406,486Direct
SaleNov 17, 2025
Common StockF1F35,344$25.3922$135.70K401,142Direct
Filing footnotes · 3
  1. F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.16 to $25.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.16 to $25.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.